TA
PTGX icon

Teachers Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Teachers Advisors’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-21,593
Closed -$185K – 3083
2018
Q1 		$185K Hold
21,593
– – ﹤0.01% 2894
2017
Q4 		$449K Buy
21,593
+5,375
+33% +$95.4K ﹤0.01% 2613
2017
Q3 		$287K Hold
16,218
– – ﹤0.01% 2854
2017
Q2 		$183K Buy
16,218
+6,757
+71% +$72.3K ﹤0.01% 3021
2017
Q1 		$121K Hold
9,461
– – ﹤0.01% 2957
2016
Q4 		$208K Buy
9,461
+1,424
+18% +$31.7K ﹤0.01% 2896
2016
Q3 		$170K Buy
+8,037
New +$110K ﹤0.01% 2923

Other funds holding PTGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Teachers Advisors's PTGX Position: Q2 2018 in Review

Teachers Advisors sold out of Protagonist Therapeutics (PTGX) in Q2 2018, closing a stake of 21,593 shares — an estimated $185K sold.

Teachers Advisors first reported a position in PTGX in Q3 2016 and held it in 7 quarters. The position peaked at $449K in Q4 2017. 69 funds tracked by Wall St. Rank hold PTGX as of Q2 2018.

  • Teachers Advisors reported no remaining Protagonist Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Teachers Advisors sold 21,593 Protagonist Therapeutics shares in Q2 2018, an estimated $185K.
  • Teachers Advisors first reported a position in Protagonist Therapeutics in Q3 2016 and held it in 7 quarters.
  • Teachers Advisors's Protagonist Therapeutics position peaked at $449K in Q4 2017.
  • 69 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2018.

Based on Teachers Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.